Sanjivani Paranteral [SANJIVIN] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Sanjivani Paranteral Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanjivani Paranteral Ltd. wins in 8 metrics, Sun Pharmaceutical Industries Ltd. wins in 11 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sanjivani Paranteral Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 25.38 36.73 Sanjivani Paranteral Ltd.
Price-to-Book Ratio 4.60 5.15 Sanjivani Paranteral Ltd.
Debt-to-Equity Ratio 19.66 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.70 3.59 Sanjivani Paranteral Ltd.
EV/EBITDA 19.72 23.61 Sanjivani Paranteral Ltd.
Profit Margin (TTM) 11.23% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 16.37% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 16.37% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 20.31% 15.08% Sanjivani Paranteral Ltd.
Return on Assets (TTM) 10.35% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-179.46M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -41.38% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 2.79 7.05 Sanjivani Paranteral Ltd.
Enterprise Value $2.17B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.94 6.66 Sanjivani Paranteral Ltd.
Gross Profit Margin (TTM) 33.22% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $61 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $6.60 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) -0.53 0.11 Sanjivani Paranteral Ltd.

Sanjivani Paranteral Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

SANJIVIN
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sanjivani Paranteral Ltd.-2.94%-1.27%-8.38%-20.81%-25.53%-35.18%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sanjivani Paranteral Ltd.-41.38%119.73%1,199.55%420.75%341.06%252.00%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Sanjivani Paranteral Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSANJIVINSUNPHARMA
Market Information
Market Cap i₹2.06B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,7433,903,142
90 Day Avg. Volume i12,6873,253,866
Last Close₹143.70₹1,788.50
52 Week Range₹126.00 - ₹268.80₹1,548.00 - ₹1,916.60
% from 52W High-46.54%-6.68%
All-Time High₹396.95 (Dec 30, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-63.80%-8.77%
Growth Metrics
Quarterly Revenue Growth0.27%0.14%
Quarterly Earnings Growth0.43%0.16%
Financial Health
Profit Margin (TTM) i0.11%0.19%
Operating Margin (TTM) i0.16%0.26%
Return on Equity (TTM) i0.20%0.15%
Debt to Equity (MRQ) i19.666.68
Cash & Liquidity
Book Value per Share (MRQ)₹36.39₹324.46
Cash per Share (MRQ)₹0.56₹115.87
Operating Cash Flow (TTM) i₹35.94M₹110.84B
Levered Free Cash Flow (TTM) i₹80.97M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Sanjivani Paranteral Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSANJIVIN (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.3836.73
Forward P/E iN/A29.48
PEG Ratio i0.703.59
Price to Sales (TTM) i2.797.05
Price to Book (MRQ) i4.605.15
Market Capitalization
Market Capitalization i₹2.06B₹3.88T
Enterprise Value i₹2.17B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.946.66
Enterprise to EBITDA i19.7223.61
Risk & Other Metrics
Beta i-0.530.11
Book Value per Share (MRQ) i₹36.39₹324.46

Financial Statements Comparison: Sanjivani Paranteral Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSANJIVIN (2025)SUNPHARMA (2025)
Revenue/Sales i695.62M520.41B
Cost of Goods Sold i443.98M121.98B
COGS % of Revenue i63.8%23.4%
Gross Profit i251.64M398.44B
Gross Margin i36.2%76.6%
Research & Development i5.74MN/A
Operating Income (EBIT) i97.32M125.81B
Operating Margin i14.0%24.2%
EBITDA i113.87M167.25B
EBITDA Margin i16.4%32.1%
Pre-Tax Income i103.52M137.52B
Pre-Tax Income % of Revenue i14.9%26.4%
Income Tax i22.58M27.72B
Income Tax % of Revenue i3.2%5.3%
Net Income (Profit) i80.94M109.65B
Profit Margin i11.6%21.1%

Balance Sheet & Liquidity Metrics

MetricSANJIVIN (2025)SUNPHARMA (2025)
Cash & Equivalents i14.85M102.69B
Total Current Assets i341.79M526.24B
Total Current Assets % of Revenue i49.1%101.1%
Total Current Liabilities i317.92M181.94B
Total Current Liabilities % of Revenue i45.7%35.0%
Long-Term Debt i52.89M3.58B
Long-Term Debt % of Revenue i7.6%0.7%
Total Shareholders Equity i398.71M724.86B
Retained Earnings i-427.89M578.62B
Retained Earnings % of Revenue i-61.5%111.2%
Property, Plant & Equipment i386,420100.36B

Cash Flow Statement Comparison

MetricSANJIVIN (2025)SUNPHARMA (2025)
Operating Cash Flow i35.94M110.84B
Operating Cash Flow % of Revenue i5.2%21.3%
Capital Expenditures i-303.49M-20.68B
Free Cash Flow i-179.46M119.44B
FCF Margin i-25.8%23.0%
Debt Repayment i0-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricSANJIVINSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.28M2.40B
Float Shares i5.99M1.07B
% Held by Insiders i58.85%55.62%
% Held by Institutions i1.07%28.69%
% Held by Public i40.08%15.69%

Dividend Analysis & Yield Comparison: Sanjivani Paranteral Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSANJIVINSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026